Significance of Hormonal Treatment in Metastatic Breast Cancer

被引：0

作者：

Demirci, Umut ^{[1
]}

Buyukberber, Suleyman ^{[1
]}

Yildiz, Ramazan ^{[1
]}

Benekli, Mustafa ^{[1
]}

Coskun, Ugur ^{[1
]}

机构：

[1] Gazi Univ, Tip Fak, Med Onkol Bilim Dali, TR-06500 Ankara, Turkey

来源：

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI | 2010年 / 20卷 / 03期

关键词：

Metastatic breast cancer; Hormonal treatment; FOLLOW-UP; THERAPY; COMBINATION; SURVIVAL; TRIAL;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In recent years mortality of breast cancer was decreased with frequent useage of mammography and effective adjuvant treatment regiments. But unfortunately we can not see the same success in metastatic breast cancer. Because we can not achive curative treatment in metastatic breast cancer; the aim of the treatment is sympthomatic improvement and increse in survival. In this case we emphasize the role of hormonal treatment in metastatic breast cancer. We give consecutive chemotherapy and hormonal treatment and show that metastatic lesions disappeared after hormonal treatment.

引用

页码：186 / 189

页数：4

共 13 条

[1]

AHMEDIN J, 2004, CA-CANCER J CLIN, V54, P8

[2] 10-YEAR FOLLOW-UP-STUDY OF PREMENOPAUSAL WOMEN WITH METASTATIC BREAST-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY [J].

FALKSON, G ;

HOLCROFT, C ;

GELMAN, RS ;

TORMEY, DC ;

WOLTER, JM ;

CUMMINGS, FJ .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (06) :1453-1458

[3]

FORBES JF, 1986, J CLIN ONCOL, V4, P186

[4] Survival of metastatic breast carcinoma patients over a 20-year period - A retrospective analysis based on individual patient data from six consecutive studies [J].

Gennari, A ;

Conte, P ;

Rosso, R ;

Orlandini, CA ;

Bruzzi, P .

CANCER, 2005, 104 (08) :1742-1750

[5] Drug therapy - Treatment of breast cancer [J].

Hortobagyi, GN .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (14) :974-984

[6]

KANTARJIAN HM, 2007, MANUAL MED ONCOLOGY, pCH20

[7]

MUSS HB, 2007, CECIL MED, P1501

[8] Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: Phase III trial results [J].

O'Shaughnessy, J ;

Miles, D ;

Vukelja, S ;

Moiseyenko, V ;

Ayoub, JP ;

Cervantes, G ;

Fumoleau, P ;

Jones, S ;

Lui, WY ;

Mauriac, L ;

Twelves, C ;

Van Hazel, G ;

Verma, S ;

Leonard, R .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (12) :2812-2823

[9]

Rahman ZU, 1999, CANCER, V85, P104, DOI 10.1002/(SICI)1097-0142(19990101)85:1<104::AID-CNCR15>3.0.CO

[10]

2-R

← 1 2 →